Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe
Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in [...]
Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in [...]
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, [...]
GlaxoSmithKline vet departs for Vifor, the rumored target of a [...]
Novartis CEO Narashimhan confirms interest in purchase of generics unit [...]
Merck, Eisai’s 007 goes down as Keytruda-Lenvima combo fails in [...]
Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M [...]
Another Samsung Bioepis? Biocon, Viatris mull merging biosimilar businesses: report [...]
Amid Aduhelm’s rocky launch, Biogen eyes large-scale layoffs: report fkansteiner [...]
BioPure set to add 120 jobs at newly completed UK [...]
Amid consumer spinoff and CEO transition, Johnson & Johnson names [...]